Colgan Richard, Johnson James R, Kuskowski Michael, Gupta Kalpana
Department of Family Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Antimicrob Agents Chemother. 2008 Mar;52(3):846-51. doi: 10.1128/AAC.01200-07. Epub 2007 Dec 17.
Emerging antimicrobial resistance among uropathogens makes the management of acute uncomplicated cystitis increasingly challenging. Few prospective data are available on the risk factors for resistance to trimethoprim-sulfamethoxazole (TMP-SMX), the drug of choice in most settings. In order to evaluate this, we prospectively enrolled women 18 to 50 years of age presenting to an urban primary care practice with symptoms of cystitis. Potentially eligible women provided a urine sample for culture and completed a questionnaire regarding putative risk factors for TMP-SMX resistance. Escherichia coli isolates were tested for clonal group A (CGA) membership by a fumC-specific PCR. Of 165 women with cystitis symptoms, 103 had a positive urine culture and were eligible for participation. E. coli was the predominant uropathogen (86%). Fifteen (14.6%) women had a TMP-SMX-resistant (TMP-SMX r) organism (all of which were E. coli). Compared with the women who had a TMP-SMX-susceptible organism, women in the TMP-SMX r group were more likely to have traveled (odds ratio [OR], 15.4; 95% confidence interval [CI], 4.4 to 54.3; P < 0.001) and to be Asian (OR, 6.1; 95% CI, 1.0 to 36.4; P = 0.048). CGA was also independently associated with TMP-SMX resistance (OR, 105; 95% CI, 6.3 to 1,777.6; P = 0.001). No association with TMP-SMX resistance was demonstrated for the use of either TMP-SMX or another antibiotic in the past 3 months or with having a child in day care. Among these women with acute uncomplicated cystitis, Asian race and recent travel were independently associated with TMP-SMX resistance. TMP-SMX r isolates were more likely to belong to CGA. Knowledge of these risk factors for TMP-SMX resistance could facilitate the accurate selection of empirical therapy.
尿路病原体中不断出现的抗菌药物耐药性使得急性单纯性膀胱炎的治疗面临越来越大的挑战。关于甲氧苄啶 - 磺胺甲恶唑(TMP - SMX)耐药的危险因素,目前几乎没有前瞻性数据,而在大多数情况下,TMP - SMX是首选药物。为了评估这一点,我们前瞻性地招募了18至50岁因膀胱炎症状到城市初级保健机构就诊的女性。符合条件的女性提供尿液样本进行培养,并完成一份关于TMP - SMX耐药假定危险因素的问卷。通过fumC特异性PCR检测大肠杆菌分离株是否属于克隆群A(CGA)。在165名有膀胱炎症状的女性中,103名尿液培养呈阳性且符合参与条件。大肠杆菌是主要的尿路病原体(86%)。15名(14.6%)女性感染了对TMP - SMX耐药(TMP - SMX r)的病原体(均为大肠杆菌)。与感染对TMP - SMX敏感病原体的女性相比,TMP - SMX r组的女性更有可能有过旅行经历(优势比[OR],15.4;95%置信区间[CI],4.4至54.3;P < 0.001)且为亚洲人(OR,6.1;95%CI,1.0至36.4;P = 0.048)。CGA也与TMP - SMX耐药独立相关(OR,105;95%CI,6.3至1777.6;P = 0.001)。在过去3个月内使用TMP - SMX或其他抗生素,或孩子在日托中心托管,均未显示与TMP - SMX耐药有关。在这些急性单纯性膀胱炎女性中,亚洲种族和近期旅行与TMP - SMX耐药独立相关。TMP - SMX r分离株更有可能属于CGA。了解这些TMP - SMX耐药的危险因素有助于准确选择经验性治疗方法。